We are pleased to announce the placement of Life Sciences Litigation Partner Dr. Timothy Best with McDermott Will & Emery in their Los Angeles office.  He was formerly a partner with Gibson Dunn where he was a member of the firm’s Intellectual Property Litigation Practice Group.

Dr. Best’s patent litigation experience has spanned work for clients in a variety of technological fields, including biotechnology and life sciences, pharmaceuticals, medical devices, image processing, semiconductor manufacture, and business methods.  He also has experience in copyright and trademark litigation.  Notably, Dr. Best played a second-chair role on a trial team that successfully defended Pfizer and Merck-Serono in a five-week jury trial against Biogen, in which the jury unanimously rejected Biogen’s damages claim and invalidated its patent, handing Pfizer and Merck-Serono one of the largest defense wins in patent litigation history.

Dr. Best is a member of the adjunct faculty at USC Gould School of Law, where he teaches Intellectual Property Litigation, and serves as a member of the Planning Committee of the USC IP Institute.  He is a member of the Judge Paul R. Michel Intellectual Property American Inn of Court.  Prior to law school, Dr. Best earned his Ph D. in Chemistry from the California Institute of Technology.

Watanabe Schwartz, the firm providing partner and practice group placement and consulting services to law firms throughout California, has facilitated over 1,500 transactions involving individual partners and groups.